pubmed-article:19318496 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:19318496 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
pubmed-article:19318496 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
pubmed-article:19318496 | lifeskim:mentions | umls-concept:C0281361 | lld:lifeskim |
pubmed-article:19318496 | lifeskim:mentions | umls-concept:C0038952 | lld:lifeskim |
pubmed-article:19318496 | lifeskim:mentions | umls-concept:C0045093 | lld:lifeskim |
pubmed-article:19318496 | lifeskim:mentions | umls-concept:C1424316 | lld:lifeskim |
pubmed-article:19318496 | lifeskim:mentions | umls-concept:C1130454 | lld:lifeskim |
pubmed-article:19318496 | lifeskim:mentions | umls-concept:C0681842 | lld:lifeskim |
pubmed-article:19318496 | lifeskim:mentions | umls-concept:C1521996 | lld:lifeskim |
pubmed-article:19318496 | lifeskim:mentions | umls-concept:C1522673 | lld:lifeskim |
pubmed-article:19318496 | pubmed:issue | 8 | lld:pubmed |
pubmed-article:19318496 | pubmed:dateCreated | 2009-4-16 | lld:pubmed |
pubmed-article:19318496 | pubmed:abstractText | Gemcitabine is a promising adjuvant treatment for patients with resected pancreatic adenocarcinoma and its use in combination with radiotherapy is under exploration. Human equilibrative nucleoside transporter 1 (hENT1) and human concentrative nucleoside transporter (hCNT) 1 and 3 are the major transporters responsible for 2',2'-difluoro-2-deoxycytidine (gemcitabine) uptake into cells. The aim of this study was to determine patients' outcome according to the expression of hENT1 and hCNT3 in tumoral cells after postoperative gemcitabine-based chemoradiation regimen. | lld:pubmed |
pubmed-article:19318496 | pubmed:language | eng | lld:pubmed |
pubmed-article:19318496 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19318496 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:19318496 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19318496 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19318496 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19318496 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19318496 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19318496 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:19318496 | pubmed:month | Apr | lld:pubmed |
pubmed-article:19318496 | pubmed:issn | 1078-0432 | lld:pubmed |
pubmed-article:19318496 | pubmed:author | pubmed-author:CassCarol ECE | lld:pubmed |
pubmed-article:19318496 | pubmed:author | pubmed-author:DevièreJacque... | lld:pubmed |
pubmed-article:19318496 | pubmed:author | pubmed-author:MackeyJohn... | lld:pubmed |
pubmed-article:19318496 | pubmed:author | pubmed-author:SalmonIsabell... | lld:pubmed |
pubmed-article:19318496 | pubmed:author | pubmed-author:LaiRaymondR | lld:pubmed |
pubmed-article:19318496 | pubmed:author | pubmed-author:YoungJamesJ | lld:pubmed |
pubmed-article:19318496 | pubmed:author | pubmed-author:Van... | lld:pubmed |
pubmed-article:19318496 | pubmed:author | pubmed-author:DemetterPiete... | lld:pubmed |
pubmed-article:19318496 | pubmed:author | pubmed-author:PeetersMarcM | lld:pubmed |
pubmed-article:19318496 | pubmed:author | pubmed-author:PolusMarcM | lld:pubmed |
pubmed-article:19318496 | pubmed:author | pubmed-author:MaréchalRapha... | lld:pubmed |
pubmed-article:19318496 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:19318496 | pubmed:day | 15 | lld:pubmed |
pubmed-article:19318496 | pubmed:volume | 15 | lld:pubmed |
pubmed-article:19318496 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:19318496 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:19318496 | pubmed:pagination | 2913-9 | lld:pubmed |
pubmed-article:19318496 | pubmed:meshHeading | pubmed-meshheading:19318496... | lld:pubmed |
pubmed-article:19318496 | pubmed:meshHeading | pubmed-meshheading:19318496... | lld:pubmed |
pubmed-article:19318496 | pubmed:meshHeading | pubmed-meshheading:19318496... | lld:pubmed |
pubmed-article:19318496 | pubmed:meshHeading | pubmed-meshheading:19318496... | lld:pubmed |
pubmed-article:19318496 | pubmed:meshHeading | pubmed-meshheading:19318496... | lld:pubmed |
pubmed-article:19318496 | pubmed:meshHeading | pubmed-meshheading:19318496... | lld:pubmed |
pubmed-article:19318496 | pubmed:meshHeading | pubmed-meshheading:19318496... | lld:pubmed |
pubmed-article:19318496 | pubmed:meshHeading | pubmed-meshheading:19318496... | lld:pubmed |
pubmed-article:19318496 | pubmed:meshHeading | pubmed-meshheading:19318496... | lld:pubmed |
pubmed-article:19318496 | pubmed:meshHeading | pubmed-meshheading:19318496... | lld:pubmed |
pubmed-article:19318496 | pubmed:meshHeading | pubmed-meshheading:19318496... | lld:pubmed |
pubmed-article:19318496 | pubmed:meshHeading | pubmed-meshheading:19318496... | lld:pubmed |
pubmed-article:19318496 | pubmed:meshHeading | pubmed-meshheading:19318496... | lld:pubmed |
pubmed-article:19318496 | pubmed:meshHeading | pubmed-meshheading:19318496... | lld:pubmed |
pubmed-article:19318496 | pubmed:meshHeading | pubmed-meshheading:19318496... | lld:pubmed |
pubmed-article:19318496 | pubmed:meshHeading | pubmed-meshheading:19318496... | lld:pubmed |
pubmed-article:19318496 | pubmed:meshHeading | pubmed-meshheading:19318496... | lld:pubmed |
pubmed-article:19318496 | pubmed:year | 2009 | lld:pubmed |
pubmed-article:19318496 | pubmed:articleTitle | Human equilibrative nucleoside transporter 1 and human concentrative nucleoside transporter 3 predict survival after adjuvant gemcitabine therapy in resected pancreatic adenocarcinoma. | lld:pubmed |
pubmed-article:19318496 | pubmed:affiliation | Department of Gastroenterology and Hepato-Pancreatology, Gastrointestinal Cancer Unit, and Department of Pathology, Erasme University Hospital, Université Libre de Bruxelles, Brussels, Belgium. rmarecha@ulb.ac.be | lld:pubmed |
pubmed-article:19318496 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:19318496 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
entrez-gene:2030 | entrezgene:pubmed | pubmed-article:19318496 | lld:entrezgene |
entrez-gene:64078 | entrezgene:pubmed | pubmed-article:19318496 | lld:entrezgene |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:19318496 | lld:entrezgene |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:19318496 | lld:entrezgene |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19318496 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19318496 | lld:pubmed |